treatment of patients with known or suspected internal contamination with radioactive cesium and/or non-radioactive thallium to increase their rates of elimination
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB31 Prussian blue
D05647 Prussian blue insoluble (USAN) <US>
USP drug classification [BR:br08302]
Electrolytes/Minerals/Metals/Vitamins
Electrolyte/Mineral/Metal Modifiers
Prussian Blue
D05647 Prussian blue insoluble (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D05647
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05647